Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > GUANFACINE HCL

GUANFACINE HCL

pharmaceutical raw materials
GUANFACINE HCL structure

GUANFACINE HCL 

structure
  • CAS No:

    29110-48-3

  • Formula:

    C9H9Cl2N3O.ClH

  • Chemical Name:

    GUANFACINE HCL

  • Synonyms:

    bs100-141;estulic;lon798;n-(aminoiminomethyl)-2,6-dichlorobenzeneacetamidehydrochloride;n-(aminoiminomethyl)-2,6-dichloro-benzeneacetamidmonohydrochloride;n-amidino-2-(2,6-dichlorophenyl)acetamidehydrochloride;N (AMINOIMINOMETHYL)-2,6-DICHLOROBENZENEACETAMIDE HYDROCHLORIDE SALT;[(2,6-DICHLOROPHENYL)ACETYL]GUANIDINE HYDROCHLORIDE

  • Categories:

    Active Pharmaceutical Ingredients  >  Circulatory System Drugs

Description

Guanfacine Hcl, an anti-hypertensive agent, is a selective α2A-adrenoceptor agonist with Kd of 31 nM and displays 60-fold selectivity over α2B-adrenoceptors. IC50 Value: 31 nM(Kd)Target: Adrenergic ReceptorGuanfacine is a sympatholytic. It is a selective α2A receptor agonist. These receptors are concentrated heavily in the prefrontal cortex and the locus coeruleus, with the potential to improve attention resulting from interaction with receptors in the former. Guanfacine lowers both syst


Guanfacine hydrochloride is a member of acetamides. It has a role as a geroprotector.|Guanfacine Hydrochloride is the hydrochloride salt form of guanfacine, a centrally acting alpha-2 adrenergic agonist with antihypertensive activity. Alpha-2 receptor stimulation by guanfacine hydrochloride results in a decreased sympathetic outflow from the vasomotor center to the heart, kidneys, and peripheral vasculature. This leads to a decrease in heart rate and peripheral vascular resistance. (NCI05)|A centrally acting antihypertensive agent with specificity towards ADRENERGIC ALPHA-2 RECEPTORS.


ChEBI: Guanfacine hydrochloride is a member of acetamides. It has a role as a geroprotector.


Guanfacine hydrochloride,N-(aminoiminomethyl)-2,6-dichlorobenzeneacetamide(Tenex), is structurally related to clonidine hydrochloride andguanabenz acetate and shares many of their pharmacologicalproperties. The drug has a longer duration of action than eitherclonidine hydrochloride or guanabenz acetate. It lasts upto 24 hours. It also requires much longer (8–12 hours) for apeak effect to occur after the drug is administered.

GUANFACINE HCL Basic Attributes

282.55

280.988953

249-443-3

PML56A160O

759121

DTXSID2045157

C47550

white

C02AC02

2925294500

Characteristics

81.5

3.53850

white

215-217℃

H2O: soluble 12mg/mL at60°C

Store at RT

LD50 in mice: 165 mg/kg orally (Coward)

Inert atmosphere,Room Temperature

Safety Information

III

6.1(b)

3249

3

6.1

CY1481000

Store at RT

P201, P202, P260, P263, P264, P270, P281, P301+P310, P308+P313, P321, P330, P405, P501

H301

3249

|Danger|H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]|P201, P202, P264, P270, P281, P301+P310, P308+P313, P321, P330, P405, and P501|Aggregated GHS information provided by 11 companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Drug Information

Treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents 6 to 17 years old for whom stimulants are not suitable, not tolerated or have been shown to be ineffective.Intuniv must be used as a part of a comprehensive ADHD treatment programme, typically including psychological, educational and social measures.|Treatment of Attention Deficit Hyperactivity Disorder (ADHD)

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)|Compounds that bind to and activate ADRENERGIC ALPHA-2 RECEPTORS. (See all compounds classified as Adrenergic alpha-2 Receptor Agonists.)

BS 100 141

GUANFACINE HCL Use and Manufacturing

Methods of Manufacturing

A solution of methyl 2-(2, 6-dichlorophenyl)acetate (75 mg, 0.26 mmol) in ethanol (3 mL) was added to a solution of guanidine hydrochloride (25 mg, 0.26 mmol) and sodium ethoxide (6.0 mg of sodium in 2 mL methanol). The prepared guanfacine crude was dissolved in 700ml 95percent ethanol, the insoluble material was filtered off. Concentrated hydrochloric acid was added to the filtrate until pH = 1, stirring for 30 min. With a rotary evaporator, at 50 ° C, a vacuum of 0.085Mpa, 60percent solvent was concentrated to remove the remaining cooling To 30 ° C, crystallization 3 hours, filtered to give crude guanfacine hydrochloride Compound 53g;The guanfacine hydrochloride crude was dissolved in 550ml of 95percent ethanol, heated to reflux, filtered hot, the filtrate was cooled to 30 , crystallization 2Hour, filtered, dried at 105 for 5 hours to obtain a finished product 32.6 g.

Uses

Antihypertensor;Alpha 2A agonist


Guanfacine hydrochloride may be used as a pharmaceutical reference standard for the determination of the analyte in bulk drug and pharmaceutical formulations by spectrophotometry and high performance liquid chromatography.


Centrally acting a-adrenoceptor agonist. Antihypertensive

Human drugs -> Intuniv -> EMA Drug Category|Antiadrenergic agents, centrally acting, Antihypertensives -> Human pharmacotherapeutic group|Human Drugs -> EU pediatric investigation plans|Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients

Computed Properties

Molecular Weight:282.5
Hydrogen Bond Donor Count:3
Hydrogen Bond Acceptor Count:1
Rotatable Bond Count:2
Exact Mass:280.988945
Monoisotopic Mass:280.988945
Topological Polar Surface Area:81.5
Heavy Atom Count:16
Complexity:256
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes

Recommended Suppliers of GUANFACINE HCL

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.